Charles J. Schneider MD

Charles J. Schneider, MD, is a medical oncologist and Clinical Professor of Medicine at the Abramson Cancer Center at the University of Pennsylvania.

Dr. Schneider earned his medical degree from University of Chicago Pritzker School of Medicine. He subsequently completed an internal medicine residency and a hematology/oncology fellowship at the Hospital of the University of Pennsylvania.

Dr. Schneider is a gastrointestinal (GI) oncologist with expertise in all subtypes of GI malignancies. He has a special interest in colorectal, anal, appendix, small intestine, and neuroendocrine tumors.

In addition to his clinical work with patients, Dr. Schneider is an active researcher, with a focus on colorectal and anal cancers. He serves as the Principal Investigator in Penn’s Phase 1 Clinical Trial Program and for several ongoing ECOG-affiliated trials in the Penn GI Oncology Clinical Research Program. He also serves as the Medical Monitor and Medical Director for other studies, one of which aims to produce an investigational new device for the FDA for the treatment of liver cancer.

Dr. Schneider is a member of several national professional organizations, including the American College of Physicians, the American Society of Clinical Oncology, and the Society for Immunotherapy of Cancer (SITC). He also holds memberships with several international organizations, including the European Society for Medical Oncology and the North American Neuroendocrine Tumor Society.

Dr. Schneider is a member of the NCCN Colon/Rectal/Anal/Small Intestine Cancers Panel.